Inactive Instrument

Carmat Stock Other OTC

Medical Equipment, Supplies & Distribution

Analysts' recommendations : Carmat

09/05/25	Carmat: Invest Securities raises target price
11/04/25	Carmat: Invest Securities still a buyer, but cuts TP
04/02/25	Carmat: Invest Securities slightly lowers its target
10/01/25	Carmat: Invest Securities upgrades to buy
09/01/25	Carmat: Oddo BHF reduces its price target

More recommendations

News in other languages : Carmat

05/03	Carmat, Ynsect… quand les pépites industrielles françaises tombent dans le gouffre de Moore
07/01	Pluxee N : Carmat, Hoffmann, LDC, Pluxee, Technip Energies... les valeurs à suivre aujourd'hui à Paris
07/01	Bourse : GTT et Technip Energy engrangent, Pluxee publie, Carmat disparaît
07/01	CARMAT : A suivre aujourd'hui
07/01	Les records continuent à tomber en bourse

More news

Managers and Directors : Carmat

Manager	Title	Age	Since
Stéphane Piat CEO	Chief Executive Officer	55	01/09/2016
Pascale d’Arbonneau DFI	Director of Finance/CFO	-	12/12/2018
Christian Latrémouille CTO	Chief Tech/Sci/R&D Officer	-	01/04/2025

Director	Title	Age	Since
Stéphane Piat BRD	Director/Board Member	55	-
Jean-Luc Lemercier BRD	Director/Board Member	68	02/01/2017
Michael Mack BRD	Director/Board Member	79	20/04/2017

More insiders

Carmat SA, formerly known as Carmat SAS is a France-based company engaged in the development and production of heart prosthesis. The Company is developing an orthotopic and biocompatible artificial heart which works like a natural heart, and which is hydraulically activated. It specializes in the development of a fully implantable orthotopic artificial heart, its electrical power supply system, and its telediagnosis system. The Company formed a network of partnerships with hospitals and various scientific companies, such as The Georges Pompidou European Hospital, The Marie Lannelongue Surgical Center, The Hospital Charles Nicolle of Rouen, Dedienne Sante, PaxiTech, Vignal Artru Industries, French Vessels, and Blood Institute, Laboratoire de Recherche Biochirurgicale and others.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!

SEIZE THE OFFER!

Market Cap	6.15M 7.13M 5.8M 5.28M 9.86M 681M 9.97M 69.08M 26.57M 347M 26.79M 26.2M 1.1B	P/E 2023	-3.09x	P/E 2024	-0.95x
Enterprise Value	59.25M 68.78M 55.89M 50.89M 95.08M 6.57B 96.07M 666M 256M 3.34B 258M 253M 10.61B	EV / Sales 2023	56.1x	EV / Sales 2024	13.5x
Free-Float	89.06%	Yield 2023 *	-	Yield 2024	-

01/09	CARMAT SAS Publishes Results Of EFICAS Clinical Study On Aeson Total Artificial Heart As Bridge-To-Transplant Therapy	CI
07/01	Carmat, Hoffmann, LDC, Pluxee, Technip Energies... Stocks to Watch Today in Paris
07/01	CARMAT: To Watch Today
07/01	Carmat, GTT, Genfit, LDC... Stocks to Watch Tomorrow in Paris
07/01	Carmat Announces Liquidation and Delisting
02/12	Only Takeover Bid for Carmat Approved by Court
02/12	Carmat: Takeover Offer Approved, 88 Jobs Saved	RE
02/12	Carmat receives takeover bid	RE
05/11	Carmat SAS submits bid for Carmat SA within ongoing receivership procedure	RE
16/10/25	CAC 40 Surges on LVMH Results and Easing US-China Tensions
15/10/25	Carmat: Judicial Recovery Continues, New Hearing Set for November 25	RE
15/10/25	Carmat says liquidation review postponed until Nov 25	RE
01/10/25	Carmat: Judicial Liquidation Request to Be Reviewed on October 14	RE

02/12	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU
05/11	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU
29/10/25	CARMAT : Inside Information / Other news releases	PU
29/10/25	CARMAT Announces Postponing the Publication of its 2025 Interim Financial Report (Six Months Ended June 30, 2025)	BU
15/10/25	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CARMAT	-.--%	-.--%	-	-	7.08M
STRYKER CORPORATION	-1.95%	-13.51%	-31.25%	-6.75%	106B
SMITH & NEPHEW PLC	0.00%	-3.48%	-28.54%	-3.89%	11.68B
GLAUKOS CORPORATION	-5.23%	-5.10%	+87.42%	+129.07%	10.6B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	-2.18%	-4.26%	-54.99%	-71.10%	4.08B
DOUBLE MEDICAL TECHNOLOGY INC.	-1.02%	-2.40%	-28.53%	+34.56%	2.42B
INSIGHT LIFETECH CO., LTD.	-3.34%	-8.43%	-	-	1.88B
INSPIRE MEDICAL SYSTEMS, INC.	+2.47%	+8.01%	-16.39%	-69.66%	1.92B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-1.11%	-1.91%	-23.15%	-28.32%	1.55B
Average	-1.37%	-2.81%	-13.63%	-2.30%	17.47B
Weighted average by Cap.	-1.97%	-9.09%	-22.26%	+1.64%

	2023	2024
Net sales	3.84M 4.45M 3.62M 3.3M 6.16M 425M 6.22M 43.13M 16.59M 216M 16.73M 16.36M 687M	7.34M 8.53M 6.93M 6.31M 11.79M 814M 11.91M 82.54M 31.75M 414M 32.02M 31.31M 1.32B
Net income	-53.87M -62.54M -50.82M -46.27M -86.45M -5.97B -87.35M -605M -233M -3.04B -235M -230M -9.65B	-51.4M -59.67M -48.48M -44.15M -82.48M -5.7B -83.34M -578M -222M -2.9B -224M -219M -9.21B
Net Debt	49.64M 57.62M 46.82M 42.63M 79.66M 5.5B 80.48M 558M 215M 2.8B 216M 212M 8.89B	53.1M 61.64M 50.09M 45.61M 85.22M 5.89B 86.1M 597M 230M 3B 231M 226M 9.51B

Carmat Stock Other OTC

Stocks

Medical Equipment, Supplies & Distribution

Valuation : Carmat

Latest news : Carmat

Analysts' recommendations : Carmat

Press Releases : Carmat

News in other languages : Carmat

Managers and Directors : Carmat

Medical Devices & Implants

Financials

Company Profile